Difference between revisions of "Team:TP-CC San Diego"
Claregao98 (Talk | contribs) |
|||
| (39 intermediate revisions by 2 users not shown) | |||
| Line 18: | Line 18: | ||
padding: 40px 80px 40px 80px; | padding: 40px 80px 40px 80px; | ||
font-size: 50px; | font-size: 50px; | ||
| − | + | padding-top: 6%; | |
} | } | ||
| Line 31: | Line 31: | ||
{ | { | ||
display: inline-block; | display: inline-block; | ||
| − | margin: | + | margin: 1%; |
} | } | ||
.icon | .icon | ||
{ | { | ||
| − | width:100%; | + | width: 100%; |
height: 100%; | height: 100%; | ||
margin: 0 auto auto auto; | margin: 0 auto auto auto; | ||
| Line 45: | Line 45: | ||
position: block; | position: block; | ||
width: 100%; | width: 100%; | ||
| − | height: | + | height: 100%; |
} | } | ||
| Line 62: | Line 62: | ||
} | } | ||
| − | + | .info | |
{ | { | ||
margin: 2% auto auto auto; | margin: 2% auto auto auto; | ||
| Line 69: | Line 69: | ||
color: black; | color: black; | ||
text-align: center; | text-align: center; | ||
| − | } | + | } |
| + | .banner | ||
| + | { | ||
| + | padding-top: -1%; | ||
| + | } | ||
| + | .text-wrapper1 | ||
| + | { | ||
| + | background: none; | ||
| + | margin: 80px 0px 0px 2%; | ||
| + | padding: 2% 2% 2% 2%; | ||
| + | width: 80%; | ||
| + | height: 100%; | ||
| + | margin: auto; | ||
| + | |||
| + | } | ||
</style> | </style> | ||
</head> | </head> | ||
<body> | <body> | ||
| − | |||
<center> | <center> | ||
| + | <div class="banner"> | ||
| + | <img style="width: 100%;margin: auto auto .5% auto;" src="https://static.igem.org/mediawiki/2017/archive/1/11/20171029225547%21T--TP-CC_San_Diego--banner.png"> | ||
| + | </div> | ||
| + | </center> | ||
| + | <!--<center> | ||
<h2 class = "main-title fade-in" style="margin: 5% 0 5% 0;">ecDNA</h2> | <h2 class = "main-title fade-in" style="margin: 5% 0 5% 0;">ecDNA</h2> | ||
| + | --> | ||
| − | <div class="text- | + | |
| − | <h3 class="day" style="margin-top: | + | <div class="text-wrapper1"> |
| + | <h3 class="day" style="margin-top: 2%;">Abstract</h3> | ||
<p style="font-size: 22px; margin-top: 20px;"> | <p style="font-size: 22px; margin-top: 20px;"> | ||
Cancer, a genetic disease resulting in uncontrollable cell growth, is mostly caused by somatic mutations acquired throughout an individual’s lifetime. Because it induces the increased expression of growth related genes, oncogene amplification is one of the driving forces of cancer cell replication. Recently, it was discovered that some oncogenes resided on extrachromosomal DNA (ecDNA). Like the DNA on chromosomes, ecDNAs are double stranded. A key difference, however, is the circular shape of ecDNAs; they are able to randomly distribute because they do not have centromeres, which increases heterogeneity in daughter cells. This can cause the cancerous tumors to develop faster resistance to current treatments. To target the ecDNA, we used CRISPR technology to create double strand breaks specifically in the ecDNA. Because ecDNA causes oncogene copy number to increase exponentially, utilizing CRISPR to create breaks in ecDNA decreases cancer cells’ replication speed. | Cancer, a genetic disease resulting in uncontrollable cell growth, is mostly caused by somatic mutations acquired throughout an individual’s lifetime. Because it induces the increased expression of growth related genes, oncogene amplification is one of the driving forces of cancer cell replication. Recently, it was discovered that some oncogenes resided on extrachromosomal DNA (ecDNA). Like the DNA on chromosomes, ecDNAs are double stranded. A key difference, however, is the circular shape of ecDNAs; they are able to randomly distribute because they do not have centromeres, which increases heterogeneity in daughter cells. This can cause the cancerous tumors to develop faster resistance to current treatments. To target the ecDNA, we used CRISPR technology to create double strand breaks specifically in the ecDNA. Because ecDNA causes oncogene copy number to increase exponentially, utilizing CRISPR to create breaks in ecDNA decreases cancer cells’ replication speed. | ||
| Line 87: | Line 107: | ||
</p> | </p> | ||
</div> | </div> | ||
| − | |||
<center> | <center> | ||
<div style="margin-top: 2%;"> | <div style="margin-top: 2%;"> | ||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Description"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Description"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e4/20171023064510%21T--TP-CC_San_Diego--brain.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e4/20171023064510%21T--TP-CC_San_Diego--brain.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Project Description</h3> | <h3 class = "page-title">Project Description</h3> | ||
| Line 99: | Line 118: | ||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Results"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Results"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e1/20171023064527%21T--TP-CC_San_Diego--beaker.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e1/20171023064527%21T--TP-CC_San_Diego--beaker.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Results</h3> | <h3 class = "page-title">Results</h3> | ||
| Line 105: | Line 124: | ||
</div> | </div> | ||
| − | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/ | + | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Model"> |
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/ | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/6/6a/20171023064653%21T--TP-CC_San_Diego--graph.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
| − | <h3 class = "page-title"> | + | <h3 class = "page-title">Modeling</h3> |
</div></a> | </div></a> | ||
</div> | </div> | ||
| − | + | </div> | |
| − | + | ||
</center> | </center> | ||
<center> | <center> | ||
| − | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/ | + | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/LabBook"> |
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/ | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/d/d7/20171023064353%21T--TP-CC_San_Diego--book.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
| − | <h3 class = "page-title"> | + | <h3 class = "page-title">Lab Notebook</h3> |
</div></a> | </div></a> | ||
</div> | </div> | ||
| − | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/ | + | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/InterLab"> |
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/ | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/2/2d/20171023064557%21T--TP-CC_San_Diego--cell.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
| − | <h3 class = "page-title"> | + | <h3 class = "page-title">Interlab Study</h3> |
</div></a> | </div></a> | ||
</div> | </div> | ||
| − | |||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Protocols"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Protocols"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/0/03/20171023064720%21T--TP-CC_San_Diego--magnifying.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/0/03/20171023064720%21T--TP-CC_San_Diego--magnifying.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Protocols</h3> | <h3 class = "page-title">Protocols</h3> | ||
| Line 140: | Line 157: | ||
<center> | <center> | ||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/MedalCriteria"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/MedalCriteria"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/4/4a/20171023064737%21T--TP-CC_San_Diego--medal.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/4/4a/20171023064737%21T--TP-CC_San_Diego--medal.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Medal Criteria</h3> | <h3 class = "page-title">Medal Criteria</h3> | ||
| Line 147: | Line 164: | ||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/HumanPractices"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/HumanPractices"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e7/20171023064751%21T--TP-CC_San_Diego--podium.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e7/20171023064751%21T--TP-CC_San_Diego--podium.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Human Practices</h3> | <h3 class = "page-title">Human Practices</h3> | ||
| Line 154: | Line 171: | ||
<div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Team"> | <div class="icon-wrapper ih-item circle effect10 top_to_bottom"><a href="https://2017.igem.org/Team:TP-CC_San_Diego/Team"> | ||
| − | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e7/20171023064541%21T--TP-CC_San_Diego--ecdnagroup.png" width = " | + | <div class="icon-wrapper img"><img src="https://static.igem.org/mediawiki/2017/archive/e/e7/20171023064541%21T--TP-CC_San_Diego--ecdnagroup.png" width = "250"></div> |
<div class="info"> | <div class="info"> | ||
<h3 class = "page-title">Team</h3> | <h3 class = "page-title">Team</h3> | ||
| Line 160: | Line 177: | ||
</div> | </div> | ||
</center> | </center> | ||
| − | |||
</body> | </body> | ||
</html> | </html> | ||
Latest revision as of 00:04, 2 November 2017
Abstract
Cancer, a genetic disease resulting in uncontrollable cell growth, is mostly caused by somatic mutations acquired throughout an individual’s lifetime. Because it induces the increased expression of growth related genes, oncogene amplification is one of the driving forces of cancer cell replication. Recently, it was discovered that some oncogenes resided on extrachromosomal DNA (ecDNA). Like the DNA on chromosomes, ecDNAs are double stranded. A key difference, however, is the circular shape of ecDNAs; they are able to randomly distribute because they do not have centromeres, which increases heterogeneity in daughter cells. This can cause the cancerous tumors to develop faster resistance to current treatments. To target the ecDNA, we used CRISPR technology to create double strand breaks specifically in the ecDNA. Because ecDNA causes oncogene copy number to increase exponentially, utilizing CRISPR to create breaks in ecDNA decreases cancer cells’ replication speed.
